Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension

Table 3

The prediction of periprocedural pulmonary hypertension variation.

Variables	Improved PH			Persistent PH
	OR	95% CI	value	OR	95% CI	value
BMI (kg/m^2)	0.873	0.730–1.044	0.137	0.865	0.721–1.039	0.120
PLT	0.997	0.987–1.008	0.629	1.005	0.996–1.015	0.278
PLR	0.987	0.977–0.997	0.010	0.994	0.985–1.003	0.208
NLR	1.182	1.036–1.350	0.013	1.181	1.032–1.352	0.016
RDW_SD	1.028	0.927–1.139	0.566	1.089	0.991–1.196	0.075
BNP (ng/L)	1.000	1.000–1.001	0.430	1.000	1.000–1.001	0.728
UA (mmol/L)	1.000	0.995–1.005	0.984	1.003	0.998–1.008	0.230
ALT	1.031	0.989–1.075	0.147	1.018	0.977–1.061	0.391
T-BIL	1.059	0.962–1.165	0.243	1.055	0.955–1.166	0.292
RVD (mm)	1.223	0.863–1.735	0.219	1.074	0.772–1.493	0.672
LAVI (ml/m^2)	1.038	0.971–1.110	0.274	1.036	0.968–1.109	0.301
PAD (mm)	1.117	0.870–1.434	0.384	1.349	1.061–1.715	0.015
LVEF (%)	1.005	0.942–1.072	0.881	1.069	0.996–1.148	0.065
E/e′ ratio	1.075	0.975–1.186	0.146	1.039	0.941–1.148	0.447
AV velocity (m/s)	2.282	1.168–4.456	0.016	2.042	1.043–3.998	0.037

No PH group as a referent. PH, pulmonary hypertension; BMI, body mass index; PLT, platelet; PLR, platelet-lymphocyte-ratio; NLR, neutrophil-to-lymphocyte ratio; RDW_SD, the red cell distribution width_Standard Deviation; BNP, B-type natriuretic peptide; UA, uric acid; ALT, alanine aminotransferase; T-BIL, serum total bilirubin; RVD, right ventricular diameter; LAVI, left atrial volume index; PAD, pulmonary artery diameter; LVEF, left ventricular ejection fraction; E/e′, early diastolic transmitral flow velocity/lateral mitral annular myocardial velocity; AV, aortic valve. , vs. No PH. The bold values indicate statistical significances ().